Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 297 clinical trials
featured
Antithrombin III (AT) Activity in Women with Severe Preeclampsia (PE) or Superimposed PE prior to 31 weeks

An observational study evaluating antithrombin III (ATIII), activity in women with PE at 23-0 to 30-6/7 weeks. Those with AT activity at < 70% will be compared to those with AT &ge

hypertension
antithrombin
antihypertensive
systolic blood pressure
  • 72 views
  • 03 Dec, 2020
  • 1 location
featured
EINSTEIN CHOICE

EINSTEIN CHOICE

  • 352 views
  • 08 Nov, 2020
  • 1 location
featured
BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery

BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery

  • 30 views
  • 25 Mar, 2021
  • 1 location
STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism

Pulmonary embolisms (PE) occur when blood clots cause a blockage of the blood supply to the lungs. A small PE located in the subsegmental pulmonary vasculature is identified as a subsegmental PE

  • 0 views
  • 25 Apr, 2021
  • 1 location
Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5%

This is a Phase 3, multicenter, randomized, controlled, parallel-group, open-label study to evaluate the effects of plasma exchange using human serum albumin 5% (PE-A 5%) in acute-on-chronic

plasma exchange
  • 0 views
  • 07 May, 2021
  • 44 locations
The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)

embolism and mortality. C. Other results include myocardial infarction, pulmonary embolism, transient ischemic attack, hospitalization, drug compliance, quality of life questionnaire (AFEQT), cognitive

  • 0 views
  • 25 Jan, 2021
Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease: a Randomized Comparison Trial

thrombosis or Pulmonary thromboembolism, 4. Percutaneous trans-luminal angioplasty on peripheral artery obstructive disease, 5. Aortic intervention or operation, 6. ESRD with renal replacement therapy).

  • 10 views
  • 22 Jan, 2021
Anti-thrombotics for Adults Hospitalized With COVID-19 (ACTIV-4)

This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic strategies for prevention of adverse outcomes in COVID-19 positive inpatients

  • 0 views
  • 08 Mar, 2021
  • 41 locations
COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis

A multicenter, adaptive, randomized platform trial evaluating the efficacy and safety of antithrombotic strategies in patients with COVID-19 following hospital discharge

  • 0 views
  • 06 May, 2021
  • 32 locations
Individualized Administration of Warfarin by Polymorphisms of VKORC1 and CYP2C9 Genes

The purpose of this study is to explore the individualized administration model of warfarin suitable for Chinese people, and provide a scientific reference for the use of warfarin to Chinese people.

  • 0 views
  • 22 Jan, 2021
  • 1 location